The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
Open accessAbstract
BACKGROUND: Acute human immunodeficiency virus type 1 (HIV-1) infection is a major contributor to transmission of HIV-1. An understanding of acute HIV-1 infection may be important in the development of treatment strategies to eradicate HIV-1 or achieve a functional cure. METHODS: We performed twice-weekly qualitative plasma HIV-1 RNA nucleic acid testing in 2276 volunteers who were at high risk for HIV-1 infection. For participants in whom acute HIV-1 infection was detected, clinical observations, quantitative measurements of plasma HIV-1 RNA levels (to assess viremia) and HIV antibodies, and results of immunophenotyping of lymphocytes were obtained twice weekly. RESULTS: Fifty of 112 volunteers with acute HIV-1 infection had two or more blood samples collected before HIV-1 antibodies were detected. The median peak viremia (6.7 log10 copies per milliliter) occurred 13 days after the first sample showed reactivity on nucleic acid testing. Reactivity on an enzyme immunoassay occurred at a median of 14 days. The nadir of viremia (4.3 log10 copies per milliliter) occurred at a median of 31 days and was nearly equivalent to the viral-load set point, the steady-state viremia that persists durably after resolution of acute viremia (median plasma HIV-1 RNA level, 4.4 log10 copies per milliliter). The peak viremia and downslope were correlated with the viral-load set point. Clinical manifestations of acute HIV-1 infection were most common just before and at the time of peak viremia. A median of one symptom of acute HIV-1 infection was recorded at a median of two study visits, and a median of one sign of acute HIV-1 infection was recorded at a median of three visits. CONCLUSIONS: The viral-load set point occurred at a median of 31 days after the first detection of plasma viremia and correlated with peak viremia. Few symptoms and signs were observed during acute HIV-1 infection, and they were most common before peak viremia. (Funded by the Department of Defense and the National Institute of Allergy and Infectious Diseases.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Infection with HIV causes an acute but brief and nonspecific influenza-like retroviral syndrome that can include fever, malaise, lymphadenopathy, pharyngitis, arthritis, or skin rash.”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [408]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Most persons experience at least one symptom; however, some might be asymptomatic or have no recognition of illness (406–409).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [408]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Dynamics of HIV viremia and antibody seroconversion in plasma donors
Fiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., Heldebrant, C. M., Smith, R., Conrad, A. J., Kleinman, S. H., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00005 · Cited by 1,306
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Sáez‐Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fènoël, V., Girault, I., Lécuroux, C., Potard, V., Versmisse, P., Mélard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,012
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
Pilcher, C. D., Tien, H. C., Eron, J. J., Vernazza, P., Leu, S., Stewart, P. W., Goh, L., & Cohen, M. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/386333 · Cited by 663
High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection
BRENNER, B. G., Roger, M., Routy, J., Moisi, D. D., Ntemgwa, M. L., Matte, C., Baril, J.-G., Thomas, R., Rouleau, D., Bruneau, J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512088 · Cited by 637
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L. B., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling, T. R., Vlahov, D., Astemborski, J. A., Hoover, D. R., Margolick, J. B., & Quinn, T. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441003 · Cited by 357
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sereti, I., Krebs, S. J., Phanuphak, N., Fletcher, J. L. K., Slike, B. M., Pinyakorn, S., O’Connell, R. J., Rupert, A. W., Chomont, N., Valcour, V., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw683 · Cited by 271
Self-citationAnanworanich, J., Chomont, N., Eller, L. A., Kroon, E. D. M. B., Tovanabutra, S., Bose, M., Nau, M. E., Fletcher, J. L. K., Tipsuk, S., Vandergeeten, C., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.024 · Cited by 239
Self-citationLi, H., Wang, S., Kong, R., Ding, W., Lee, F.-H., Parker, Z., Kim, E., Learn, G. H., Hahn, P., Policicchio, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606636113 · Cited by 222
Jülg, B. D., Dee, L., Ananworanich, J., Barouch, D. H., Bar, K. J., Caskey, M. F., Colby, D. J., Dawson, L., Dong, K. L., Dubé, K., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30052-9 · Cited by 201
Self-citationT-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
Knox, J. J., Buggert, M., Kardava, L., Seaton, K. E., Eller, M. A., Canaday, D. H., Robb, M. L., Ostrowski, M., Deeks, S. G., Slifka, M. K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92943 · Cited by 176
Self-citationRutstein, S. E., Ananworanich, J., Fidler, S. J., Johnson, C., Sanders, E. J., Sued, O. G., Sáez‐Cirión, A., Pilcher, C. D., Fraser, C., Cohen, M. S., et al. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21579 · Cited by 134
Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication
Guo, H., Wang, Q., Ghneim, K., Wang, L., Rampanelli, E., Holley-Guthrie, E., Cheng, L., Garrido, C., Margolis, D. M., Eller, L. A., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00898-1 · Cited by 115
Self-citationLate diagnosis of HIV : An updated consensus definition
Croxford, S., Stengaard, A. R., Brännström, J., Combs, L., Dedes, N., Girardi, E., Grabar, S., Kirk, O., Kuchukhidze, G., Lazarus, J. V., et al. (2022) · HIV Medicine · doi:10.1111/hiv.13425 · Cited by 113
Establishment of latent HIV-1 reservoirs: what do we really know?
Vanhamel, J., Bruggemans, A., & Debyser, Z. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30275-2 · Cited by 125
Krebs, S. J., Kwon, Y. D., Schramm, C. A., Law, W. H., Donofrio, G. C., Zhou, K. H., Gift, S. K., Dussupt, V., Georgiev, I. S., Schätzle, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.008 · Cited by 115
Self-citationThe effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
Donnell, D. J., Ramos, E. M., Celum, C., Baeten, J. M., Dragavon, J., Tappero, J. W., Lingappa, J. R., Ronald, A., Fife, K. H., & Coombs, R. W. (2017) · AIDS · doi:10.1097/qad.0000000000001577 · Cited by 113
Crowell, T. A., Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E. D. M. B., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30053-0 · Cited by 108
Self-citationElliott, T., Sanders, E. J., Doherty, M. C., Ndung’u, T., Cohen, M. S., Patel, P., Cairns, G., Rutstein, S. E., Ananworanich, J., Brown, C. S., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25419 · Cited by 110
Leyre, L., Kroon, E. D. M. B., Vandergeeten, C., Sacdalan, C., Colby, D. J., Buranapraditkun, S., Schuetz, A., Chomchey, N., de Souza, M. S., Bakeman, W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav3491 · Cited by 112
Self-citationDong, K. L., Moodley, A., Kwon, D. S., Ghebremichael, M. S., Dong, M., Ismail, N., Ndhlovu, Z. M., Mabuka, J. M., Muema, D., Pretorius, K., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30146-7 · Cited by 107
Takata, H., Buranapraditkun, S., Kessing, C. F., Fletcher, J. L. K., Muir, R., Tardif, V., Cartwright, P., Vandergeeten, C., Bakeman, W., Nichols, C. N., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1809 · Cited by 107
Self-citationMasenga, S. K., Mweene, B. C., Luwaya, E. L., Muchaili, L., Chona, M., & Kirabo, A. (2023) · Cells · doi:10.3390/cells12101351 · Cited by 114
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth
Roark, R. S., Li, H. J., Williams, W. B., Chug, H., Mason, R. D., Gorman, J., Wang, S., Lee, F.-H., Rando, J. M., Bonsignori, M., et al. (2020) · Science · doi:10.1126/science.abd2638 · Cited by 105
Downs, J. A., Dupnik, K. M., van Dam, G. J., Urassa, M., Lutonja, P., Kornelis, D., de Dood, C. J., Hoekstra, P. T., Kanjala, C., Isingo, R., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005968 · Cited by 96
HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections
Gantner, P., Buranapraditkun, S., Pagliuzza, A., Dufour, C., Pardons, M., Mitchell, J. L., Kroon, E. D. M. B., Sacdalan, C., Tulmethakaan, N., Pinyakorn, S., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.030 · Cited by 89
Self-citationAugmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
Ndhlovu, Z. M., Kazer, S. W., Nkosi, T., Ogunshola, F. J., Muema, D., Anmole, G., Swann, S. A., Moodley, A., Dong, K. L., Reddy, T., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau0528 · Cited by 81
Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe
Blanquart, F., Wymant, C., Cornelissen, M. T. E., Gall, A., Bakker, M. E., Bezemer, D., Hall, M. D., Hillebregt, M., Ong, S. H., Albert, J., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001855 · Cited by 80
Muema, D., Akilimali, N. A., Ndumnego, O. C., Rasehlo, S. S., Durgiah, R., Ojwach, D. B. A., Ismail, N., Dong, M., Moodley, A., Dong, K. L., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01529-6 · Cited by 78
Stannah, J., Soni, N., Lam, J. K. S., Giguère, K., Mitchell, K. M., Kronfli, N., Larmarange, J., Moh, R., Nouaman, M., Kouamé, G. M., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(23)00111-x · Cited by 76
Evolution and Diversity of Immune Responses during Acute HIV Infection
Kazer, S. W., Walker, B. D., & Shalek, A. K. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.015 · Cited by 77
Global variability of the human IgG glycome
Štambuk, J., Nakić, N., Vučković, F., Pučić‐Baković, M., Razdorov, G., Trbojević‐Akmačić, I., Novokmet, M., Keser, T., Vilaj, M. Ć., Štambuk, T., et al. (2020) · Aging · doi:10.18632/aging.103884 · Cited by 71
Self-citationWright, E., Grulich, A. E., Roy, K., Boyd, M. A., Cornelisse, V. J., Russell, D. B., O’Donnell, D., Whittaker, B., Crooks, L., & Zablotska, I. (2017) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30338-1 · Cited by 71
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States
Neilan, A. M., Landovitz, R. J., Le, M. H., Grinsztejn, B., Freedberg, K. A., McCauley, M., Wattananimitgul, N., Cohen, M. S., Ciaranello, A. L., Clement, M. E., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-1548 · Cited by 72
Insight into treatment of HIV infection from viral dynamics models
Hill, A. L., Rosenbloom, D. I. S., Nowak, M. A., & Siliciano, R. F. (2018) · Immunological Reviews · doi:10.1111/imr.12698 · Cited by 77
Massanella, M., Ignacio, R. B., Lama, J. R., Pagliuzza, A., Dasgupta, S., Alfaro, R., Ríos, J., Ganoza, C., Pinto-Santini, D., Gilada, T., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00010-0 · Cited by 75
Estimation of the incubation period of COVID-19 using viral load data
Ejima, K., Kim, K. S., Ludema, C., Bento, A. I., Iwanami, S., Fujita, Y., Ohashi, H., Koizumi, Y., Watashi, K., Aihara, K., et al. (2021) · Epidemics · doi:10.1016/j.epidem.2021.100454 · Cited by 65
Kroon, E. D. M. B., Phanuphak, N., Shattock, A. J., Fletcher, J. L. K., Pinyakorn, S., Chomchey, N., Akapirat, S., de Souza, M. S., Robb, M. L., Kim, J. H., et al. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21708 · Cited by 65
Self-citationLessons from acute HIV infection
Robb, M. L., & Ananworanich, J. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000316 · Cited by 64
Self-citationAmpt, F. H., Willenberg, L., Agius, P. A., Chersich, M., Luchters, S. M. F., & Lim, M. S. C. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021779 · Cited by 61
Primary HIV-1 infection in users of pre-exposure prophylaxis
Ambrosioni, J., Petit, E., Liégeon, G., Laguno, M., & Miró, J. M. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30271-x · Cited by 61
Depression and Anxiety are Common in Acute HIV Infection and Associate with Plasma Immune Activation
on behalf of the RV254/SEARCH 010 Study Group, Hellmuth, J. M., Colby, D. J., Valcour, V., Suttichom, D., Spudich, S., Ananworanich, J., Prueksakaew, P., Sailasuta, N., Allen, I. E., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1788-4 · Cited by 55
Self-citationCrowell, T. A., Colby, D. J., Pinyakorn, S., Fletcher, J. L. K., Kroon, E., Schuetz, A., Krebs, S. J., Slike, B. M., Leyre, L., Chomont, N., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1063 · Cited by 55
Self-citationDynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection
Lal, K. G., Kim, D., Costanzo, M. C., Creegan, M., Leeansyah, E., Dias, J., Paquin‐Proulx, D., Eller, L. A., Schuetz, A., Phuang‐Ngern, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13975-9 · Cited by 55
Self-citationWhite, D. A. E., Giordano, T. P., Pasalar, S., Jacobson, K. R., Glick, N. R., Sha, B. E., Mammen, P., Hunt, B. R., Todorovic, T., Moreno-Walton, L. A., et al. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.11.027 · Cited by 52
Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women
Pankau, M. D., Reeves, D. B., Harkins, E., Ronen, K., Jaoko, W. G., Mandaliya, K. N., Graham, S. M., McClelland, R. S., Matsen, F. A., IV, Schiffer, J. T., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008286 · Cited by 53
Li, H., Wang, S., Lee, F.-H., Roark, R. S., Murphy, A. I., Smith, J., Zhao, C., Rando, J. M., Chohan, N., Ding, Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00071-21 · Cited by 50
Wright, E., Grulich, A. E., Roy, K., Boyd, M. A., Cornelisse, V. J., Russell, D. B., O’Donnell, D., Whittaker, B., Crooks, L., & Zablotska, I. (2018) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30260-0 · Cited by 51
Kijak, G. H., Sanders‐Buell, E., Chenine, A.-L., Eller, M. A., Goonetilleke, N. P., Thomas, R., Leviyang, S., Harbolick, E. A., Bose, M., Pham, P. T., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006510 · Cited by 49
Self-citationVariations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
Yarzabek, B., Zaitouna, A. J., Olson, E. C., Silva, G. N., Geng, J., Geretz, A., Thomas, R., Krishnakumar, S., Ramón, D. S., & Raghavan, M. (2018) · eLife · doi:10.7554/elife.34961 · Cited by 47
Hingrat, Q. L., Sereti, I., LANDAY, A. L., Pandrea, I., & Apetrei, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695674 · Cited by 52
Melatonin enhances survival and preserves functional integrity of stem cells: A review
Lee, M. S.-S., Yin, T., Sung, P., Chiang, J. Y., Sun, C., & Yip, H. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12372 · Cited by 45
Hsu, D. C., Sunyakumthorn, P., Wegner, M. D., Schuetz, A., Silsorn, D., Estes, J. D., Deléage, C., Tomusange, K., Lakhashe, S. K., Ruprecht, R. M., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00222-18 · Cited by 42
Self-citationHIV integration in the human brain is linked to microglial activation and 3D genome remodeling
Plaza-Jennings, A. L., Valada, A., O’Shea, C. P., Iskhakova, M., Hu, B., Javidfar, B., Hutta, G. B., Lambert, T. Y., Murray, J., Kassim, B. S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.016 · Cited by 42
Takata, H., Kakazu, J. C., Mitchell, J. L., Kroon, E. D. M. B., Colby, D. J., Sacdalan, C., Bai, H., Ehrenberg, P. K., Geretz, A., Buranapraditkun, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104253 · Cited by 43
Self-citationCarlisle, L. A., Turk, T., Kusejko, K., Metzner, K. J., Leemann, C., Schenkel, C. D., Tschumi, N., Posada-Céspedes, S., Beerenwinkel, N., Böni, J., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz094 · Cited by 38
Inference of Transmission Network Structure from HIV Phylogenetic Trees
Giardina, F., Romero-Severson, E. O., Albert, J., Britton, T., & Leitner, T. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005316 · Cited by 38
Hsu, K., & Rakhmanina, N. Y. (2021) · PEDIATRICS · doi:10.1542/peds.2021-055207 · Cited by 37
Reeves, D. B., Huang, Y., Duke, E. R., Mayer, B. T., Ojeda, E. F. C., Boshier, F. A. T., Swan, D. A., Rolland, M., Robb, M. L., Mascola, J. R., et al. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007626 · Cited by 36
Self-citationTeigler, J. E., Leyre, L., Chomont, N., Slike, B. M., Jian, N., Eller, M. A., Phanuphak, N., Kroon, E. D. M. B., Pinyakorn, S., Eller, L. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98420 · Cited by 35
Self-citationRV144 HIV-1 vaccination impacts post-infection antibody responses
Mdluli, T., Jian, N., Slike, B. M., Paquin‐Proulx, D., Donofrio, G. C., Alrubayyi, A., Gift, S. K., Grande, R. C., Bryson, M., Lee, A. D., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009101 · Cited by 35
Self-citationPrimary HIV infection: clinical presentation, testing, and treatment.
Henn, A., Flateau, C., & Gallien, S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0588-3 · Cited by 34
Strong sex bias in elite control of paediatric HIV infection
Vieira, V., Zuidewind, P., Muenchhoff, M., Roider, J., Millar, J. R., Clapson, M., Zyl, A. V., Shingadia, D. V., Adland, E., Athavale, R., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002043 · Cited by 34
Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection
Manak, M., Jagodzinski, L. L., Shutt, A., Malia, J. A., Leos, M., Ouellette, J., Akapirat, S., Colby, D. J., Phanuphak, N., Eller, L. A., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00757-19 · Cited by 34
Self-citationRolland, M., Tovanabutra, S., Dearlove, B. L., Li, Y., Owen, C. L., Lewitus, É., Sanders‐Buell, E., Bose, M., O’Sullivan, A. M., Rossenkhan, R., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008179 · Cited by 35
Self-citationTularaemia – a diagnostic challenge
Wawszczak, M., Banaszczak, B., & Rastawicki, W. (2021) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/139242 · Cited by 34
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition
Seaton, K. E., Huang, Y., Karuna, S., Heptinstall, J., Brackett, C., Chiong, K. T., Zhang, L., Yates, N. L., Sampson, M., Rudnicki, E., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104590 · Cited by 33
Impact of early cART on HIV blood and semen compartments at the time of primary infection
Chéret, A., Durier, C., Mélard, A., Ploquin, M. J.-Y., Heitzmann, J., Lécuroux, C., Avettand-Fènoël, V., David, L., Pialoux, G., Chennebault, J.-M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180191 · Cited by 33
Pastor, L., Urrea, V., Carrillo, J., Parker, E., de la Fuente, L., Jairoce, C., Mandomando, I., Naniche, D., & Blanco, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01925 · Cited by 34
Benefits of antiretroviral therapy initiation during acute HIV infection
Clercq, J. D., Rutsaert, S., Scheerder, M. D., Verhofstede, C., Callens, S. F. J., & Vandekerckhove, L. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1770413 · Cited by 32
Dijkstra, M., de Bree, G. J., Stolte, I. G., Davidovich, U., Sanders, E. J., Prins, M., & van der Loeff, M. F. S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2508-4 · Cited by 32
Westfall, D. H., Deng, W., Pankow, A. P., Murrell, H., Chen, L., Zhao, H. C., Williamson, C. E., Rolland, M., Murrell, B., & Mullins, J. I. (2024) · Virus Evolution · doi:10.1093/ve/veae019 · Cited by 31
Self-citationBuggert, M., Nguyen, S., McLane, L. M., Steblyanko, M. A., Anikeeva, N., Paquin‐Proulx, D., Estrada, P. M. D. R., Ablanedo‐Terrazas, Y., Noyan, K., Reuter, M. A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006973 · Cited by 31
Self-citationRetractedEssential trace elements and progression and management of HIV infection
Shah, K. K., Verma, R., Oleske, J. M., Scolpino, A. J., & Bogden, J. D. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.08.001 · Cited by 31
Mimics of Monkeypox: Considerations for the emergency medicine clinician
Long, B., Liang, S. Y., Carius, B. M., Chavez, S., Gottlieb, M. A., Koyfman, A., & Brady, W. J. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.01.007 · Cited by 31
Neurologic sequelae of primary HIV infection
Brew, B. J., & Garber, J. Y. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00006-2 · Cited by 29
Modeling the immune response to HIV infection
Conway, J. M., & Ribeiro, R. M. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.10.006 · Cited by 29
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa
Janes, H., Corey, L., Ramjee, G., Carpp, L. N., Lombard, C. J., Cohen, M. S., Gilbert, P. B., & Gray, G. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0031 · Cited by 28
Vieira, V. A., Millar, J., Adland, E., Muenchhoff, M., Roider, J., Guash, C. F., Peluso, D., Thome, B. D. C., García-Guerrero, M. C., Puertas, M. C., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003078 · Cited by 26
Reeves, D. B., Mayer, B. T., deCamp, A. C., Huang, Y., Zhang, B., Carpp, L. N., Magaret, C. A., Juraska, M., Gilbert, P. B., Montefiori, D. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43384-y · Cited by 25
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivo
Geretz, A., Ehrenberg, P. K., Clifford, R., Laliberté, A., Bozzo, C. P., Eiser, D., Kundu, G., Yum, L. K., Apps, R., Creegan, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg0873 · Cited by 26
Self-citationOutcomes of Acutely HIV-1-Infected Individuals following Rapid Antiretroviral Therapy Initiation
Girometti, N., Nwokolo, N. C., McOwan, A., & Whitlock, G. G. (2016) · Antiviral Therapy · doi:10.3851/imp3080 · Cited by 25
Partner services in adults with acute and early HIV infection
Green, N., Hoenigl, M., Chaillon, A., Anderson, C. M., Pond, S. L. K., Smith, D. M., & Little, S. J. (2016) · AIDS · doi:10.1097/qad.0000000000001308 · Cited by 25
Ananworanich, J., Eller, L. A., Pinyakorn, S., Kroon, E. D. M. B., Sriplenchan, S., Fletcher, J. L. K., Suttichom, D., Bryant, C., Trichavaroj, R., Dawson, P. M., et al. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21652 · Cited by 24
Self-citationDifferences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
Sanders, E. J., Price, M. A., Karita, E., Kamali, A., Kilembe, W., Bekker, L., Lakhi, S., Inambao, M., Anzala, O. A., Fast, P., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001659 · Cited by 23
Acute HIV-1 infection viremia associate with rebound upon treatment interruption
Mdluli, T., Li, Y., Pinyakorn, S., Reeves, D. B., Ojeda, E. F. C., Yates, A. M., Intasan, J., Tipsuk, S., Phanuphak, N., Sacdalan, C., et al. (2022) · Med · doi:10.1016/j.medj.2022.06.009 · Cited by 23
Self-citationClercq, J. D., Scheerder, M. D., Mortier, V., Verhofstede, C., Vandecasteele, S. J., Allard, S. D., Necsoi, C., Wit, S. D., Gerlo, S., & Vandekerckhove, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1337316 · Cited by 26
A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
Ananthaswamy, N., Fang, Q., AlSalmi, W., Jain, S., Chen, Z., Klose, T., Sun, Y., Liu, Y., Mahalingam, M., Chand, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08825-7 · Cited by 23
Self-citationChen, J., Ramendra, R., Lu, H., & Routy, J. (2018) · Future Virology · doi:10.2217/fvl-2018-0110 · Cited by 22
Sex Differences in the Treatment of HIV
Cohn, J., Ake, J. A., Moorhouse, M. A., & Godfrey, C. C. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00499-x · Cited by 22
Wansom, T., Pinyakorn, S., Kolsteeg, C., Kroon, E. D. M. B., Sacdalan, C., Chomchey, N., Ananworanich, J., Vasan, S., Phanuphak, N., & Colby, D. J. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002356 · Cited by 21
Self-citationNaidoo, K. K., Ndumnego, O. C., Ismail, N., Dong, K. L., & Ndung’u, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738743 · Cited by 21
Chand, S., Messina, E., AlSalmi, W., Ananthaswamy, N., Gao, G., Uritskiy, G., Padilla-Sanchez, V., Mahalingam, M., Peachman, K. K., Robb, M. L., et al. (2017) · Virology · doi:10.1016/j.virol.2017.05.016 · Cited by 22
Self-citationJilg, N., & Li, J. Z. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.04.007 · Cited by 23
Townsley, S., Donofrio, G. C., Jian, N., Leggat, D. J., Dussupt, V., Mendez-Rivera, L., Eller, L. A., Cofer, L., Choe, M., Ehrenberg, P. K., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.01.016 · Cited by 21
Self-citationWhat Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans?Preprint
Martins, M. A., & Watkins, D. I. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029504 · Cited by 21
A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trials
Zolla‐Pazner, S., Michael, N. L., & Kim, J. H. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00073-4 · Cited by 20
Self-citationCurrent advances in HIV vaccine preclinical studies using Macaque models
Liang, B., Li, H., Li, L., Omange, R. W., Hai, Y., & Luo, M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.094 · Cited by 20
Hassan, A. S., Hare, J., Gounder, K., Nazziwa, J., Karlson, S., Olsson, L., Streatfield, C., Kamali, A., Karita, E., Kilembe, W., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab139 · Cited by 19
Li, S. S., Hickey, A. C., Shangguan, S., Ehrenberg, P. K., Geretz, A., Butler, L., Kundu, G., Apps, R., Creegan, M., Clifford, R., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.005 · Cited by 19
Self-citationPerkins, M. J., Bradley, W. P. L., Lalani, T., Agan, B. K., Whitman, T. J., Ferguson, T. M., Okulicz, J. F., & Ganesan, A. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001393 · Cited by 19
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
Cheng, H. D., Grimm, S. K., Gilman, M. S. A., Gwom, L. C., Sok, D., Sundling, C., Donofrio, G. C., Hedestam, G. B. K., Bonsignori, M., Haynes, B. F., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97018 · Cited by 19
Self-citationPastor, L., Langhorst, J., Schröder, D., Casellas, A., Rüffer, A., Carrillo, J., Urrea, V., Massora, S., Mandomando, I., Blanco, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218000 · Cited by 18
Timing HIV infection with a simple and accurate population viral dynamics model
Reeves, D. B., Rolland, M., Dearlove, B. L., Li, Y., Robb, M. L., Schiffer, J. T., Gilbert, P. B., Ojeda, E. F. C., & Mayer, B. T. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0314 · Cited by 17
Self-citationBoshier, F. A. T., Reeves, D. B., Duke, E. R., Swan, D. A., Prlic, M., Ojeda, E. F. C., & Schiffer, J. T. (2022) · Journal of Virus Eradication · doi:10.1016/j.jve.2022.100091 · Cited by 17
Metadata
- Authors
- Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., Jagodzinski, L. L., Malia, J., Manak, M., de Souza, M. S., Tovanabutra, S., Sanders-Buell, E., Rolland, M., Dorsey-Spitz, J., Eller, M. A., Milazzo, M., Li, Q., Lewandowski, A., Wu, H., Swann, E., O’Connell, R. J., Peel, S., Dawson, P., Kim, J. H., & Michael, N. L.
- Affiliations
- Henry M. Jackson Foundation (US)
- Armed Forces Research Institute of Medical Science (TH)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-02
- Volume
- 374
- Issue
- 22
- Pages
- 2120-2130
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5111628
- OpenAlex
- W2402980652
- Cited by
- 283
- References
- 39
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 22 · 2023: 31 · 2022: 23 · 2021: 31 · 2020: 31 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 14
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01ai002642-013)
- National Institute of Allergy and Infectious Diseases (Y01 AI002642, Y1-AI-2642-17)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- acute HIV-1 infection, HIV-1 viremia, viral load set point, HIV-1 viral load, HIV-1 antibodies, clinical symptoms and signs, HIV transmission, functional cure, East Africa, Thailand
- MeSH terms
- Adolescent, Adult, Africa, Eastern, Antibodies, Viral, Female, Humans, Male, Middle Aged, Prospective Studies, RNA, Viral, Thailand, Viremia, HIV-1, HIV Infections, Disease Progression, CD4 Lymphocyte Count, Viral Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review